Last reviewed · How we verify

NCT05503628

A Measurement Study of TIS-modNV and AccuGait Force Platform in People With MS

Status unknown Last updated 19 August 2022
What this trial tests

trial in Multiple Sclerosis in 60 participants. Status unknown.

Timeline
15 August 2022
Primary endpoint
1 January 2023
1 January 2023

Quick facts

Lead sponsorNordlandssykehuset HF
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date15 August 2022
Primary completion1 January 2023
Estimated completion1 January 2023
Sites1 location across Norway

Conditions studied

Sponsor

Nordlandssykehuset HF

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current project will fill a knowledge gap in the follow-up of people with Multiple Sclerosis (MS) with mild and moderate disability levels, with the purpose to assess the adequacy of measurement tools for trunk control and balance, functions that are pre-requisites for optimal performance in everyday physical activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Nordlandssykehuset HF trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503628.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing